Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Twin Cities Business에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Twin Cities Business 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
136. Pneumeric Founder/CEO Dr. John Aho
Manage episode 428154458 series 2501322
Twin Cities Business에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Twin Cities Business 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Dr. Aho is a surgeon and scientist with an insatiable appetite for invention and more than 20 patents to his name. He was still in his surgical residency at Mayo Clinic when he spotted an opportunity that led him to develop a medical device now in use around the world. Tension pneumothorax is a life-threatening emergency that occurs when air builds up between the lungs and chest wall. It’s not especially common, but it’s one of those medical situations that TV medical dramas often act out because the way to treat it is to jam a large needle into the chest and wait to hear a gush of air. It occurred to Aho: there had to be a better way. He developed the Capnospot, a device that provides visual confirmation that treatment of tension pneumothorax has been successful. The Capnospot is now standard equipment on ambulances and in emergency rooms everywhere, from Minnesota to Poland. It's the first product to be released by Aho’s parent company, Pneumeric. But it took five years to get here, and challenges persist, from manufacturing to marketing. Aho walks us through the long, expensive process of earning FDA approval for a medical device. “I would have raised more money, earlier,” he says. “Everything takes twice as long, and costs twice as much as you expect.” He’s raised $2.2 million to date. Aho says venture capital for medical devices tends to go to the really big ideas, rather than “little innovations,” like the Capnospot, that improve on everyday treatments. We discuss the opportunities, and the challenges, of being both practicing surgeon and entrepreneur. “Being a doctor, you get to help people,” Aho says. “Doing a medical device, I get to help people on a system wide, national and international scale.” Following our conversation with Aho, we go back to the classroom with the University of St. Thomas Opus College of Business where Dan McLaughlin is a senior executive fellow who teaches health care management. He explains why Aho's path to successful medtech developer is unique; most medtech innovation comes out of big companies that employ teams of scientists. He points out the value of basic business training in helping entrepreneurial thinkers turn their ideas into business.
…
continue reading
144 에피소드
Manage episode 428154458 series 2501322
Twin Cities Business에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Twin Cities Business 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Dr. Aho is a surgeon and scientist with an insatiable appetite for invention and more than 20 patents to his name. He was still in his surgical residency at Mayo Clinic when he spotted an opportunity that led him to develop a medical device now in use around the world. Tension pneumothorax is a life-threatening emergency that occurs when air builds up between the lungs and chest wall. It’s not especially common, but it’s one of those medical situations that TV medical dramas often act out because the way to treat it is to jam a large needle into the chest and wait to hear a gush of air. It occurred to Aho: there had to be a better way. He developed the Capnospot, a device that provides visual confirmation that treatment of tension pneumothorax has been successful. The Capnospot is now standard equipment on ambulances and in emergency rooms everywhere, from Minnesota to Poland. It's the first product to be released by Aho’s parent company, Pneumeric. But it took five years to get here, and challenges persist, from manufacturing to marketing. Aho walks us through the long, expensive process of earning FDA approval for a medical device. “I would have raised more money, earlier,” he says. “Everything takes twice as long, and costs twice as much as you expect.” He’s raised $2.2 million to date. Aho says venture capital for medical devices tends to go to the really big ideas, rather than “little innovations,” like the Capnospot, that improve on everyday treatments. We discuss the opportunities, and the challenges, of being both practicing surgeon and entrepreneur. “Being a doctor, you get to help people,” Aho says. “Doing a medical device, I get to help people on a system wide, national and international scale.” Following our conversation with Aho, we go back to the classroom with the University of St. Thomas Opus College of Business where Dan McLaughlin is a senior executive fellow who teaches health care management. He explains why Aho's path to successful medtech developer is unique; most medtech innovation comes out of big companies that employ teams of scientists. He points out the value of basic business training in helping entrepreneurial thinkers turn their ideas into business.
…
continue reading
144 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.